These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7515682)

  • 21. Unexpected relative aqueous solubilities of a phosphotyrosine analogue and two phosphonate derivatives.
    Boresch S; Leitgeb M; Beselman A; MacKerell AD
    J Am Chem Soc; 2005 Apr; 127(13):4640-8. PubMed ID: 15796529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.
    Oligino L; Lung FD; Sastry L; Bigelow J; Cao T; Curran M; Burke TR; Wang S; Krag D; Roller PP; King CR
    J Biol Chem; 1997 Nov; 272(46):29046-52. PubMed ID: 9360978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
    Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
    Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
    Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
    Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
    Nakamura K; Brauweiler A; Cambier JC
    J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise and enantioselective synthesis of Fmoc-Pmp(But)2-OH and design of potent Pmp-containing Grb2-SH2 domain antagonists.
    Li P; Zhang M; Peach ML; Liu H; Yang D; Roller PP
    Org Lett; 2003 Aug; 5(17):3095-8. PubMed ID: 12916990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptides as Baits for the Coprecipitation of SH2 Domain-Containing Proteins.
    Kiani A; Rios P; Köhn M
    Methods Mol Biol; 2023; 2705():359-369. PubMed ID: 37668984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library.
    Beebe KD; Wang P; Arabaci G; Pei D
    Biochemistry; 2000 Oct; 39(43):13251-60. PubMed ID: 11052678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
    Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
    Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
    Song YL; Tan J; Luo XM; Long YQ
    Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring Protein Tyrosine Phosphatase Activity Dependent on SH2 Domain-Mediated Regulation.
    Rios P; Kiani A; Köhn M
    Methods Mol Biol; 2023; 2705():351-358. PubMed ID: 37668983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors.
    Burke TR; Luo J; Yao ZJ; Gao Y; Zhao H; Milne GW; Guo R; Voigt JH; King CR; Yang D
    Bioorg Med Chem Lett; 1999 Feb; 9(3):347-52. PubMed ID: 10091682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical dissection of the effects of tyrosine phosphorylation of SHP-2.
    Lu W; Shen K; Cole PA
    Biochemistry; 2003 May; 42(18):5461-8. PubMed ID: 12731888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains.
    Gao Y; Wu L; Luo JH; Guo R; Yang D; Zhang ZY; Burke TR
    Bioorg Med Chem Lett; 2000 May; 10(9):923-7. PubMed ID: 10853661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR analysis of interactions of a phosphatidylinositol 3'-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites.
    Günther UL; Liu Y; Sanford D; Bachovchin WW; Schaffhausen B
    Biochemistry; 1996 Dec; 35(48):15570-81. PubMed ID: 8952511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides.
    Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR
    Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.